Study of Tolerability, Safety, and Pharmacokinetics of ZL-82 in Healthy Adult Subjects.

Conditions: Rheumatoid Arthritis (RA); Inflammatory Bowel Disease - IBD1 Interventions: Drug: ZL-82 12.5mg; Drug: ZL-82 25mg; Drug: ZL-82 50mg; Drug: ZL-82 100mg; Drug: ZL-82 200mg; Drug: ZL-82 300mg; Drug: ZL-82 450mg; Drug: ZL-82 600mg Sponsors: Chengdu Zenitar Biomedical Technology Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials